register

News & Trends - Pharmaceuticals

Sanofi-Queensland Government partnership paves way for highly-skilled medical research roles

Health Industry Hub | March 14, 2023 |

Pharma News: The $280 million Translational Science Hub, a partnership announced in December by Sanofi and the Queensland Government, is utilising the laboratories and infrastructure at the University of Queensland and Griffith University.

Sanofi has opened the first wave of senior medical research career opportunities available at the Translational Science Hub in Queensland.

The Translational Science Hub will initially focus on the evaluation of a new generation of mRNA vaccines and the development of mRNA immunisations, including a world-first mRNA vaccine for chlamydia.

Dr Steven Miles MP, Queensland Deputy Premier, said “The Translational Science Hub is set to create up to 200 jobs and deliver long-term benefits for local manufacturing, the biomedical supply chain, and the health of Queenslanders. It’s an attractive offering for medical research specialists, to be linked with global experts and to put your mark on home-grown research and innovation.”

Sanofi is on the look-out for a Brisbane-based Director of Clinical Operations, a Global Clinical Development Strategic Lead, Global Study Managers, a Strategic Partnerships Lead and a Project Coordinator.

Dr Iris Depaz, Country Medical Lead, Sanofi ANZ, stated “We are offering Global positions located in Queensland. The people we hire will have regular contact with Sanofi scientists in France and the US, while also working with our university partners in Queensland to develop the next generation of vaccines. This collaboration and knowledge sharing will accelerate the development of vaccine technology that has the potential to improve public health.

“These newly opened positions are truly special career opportunities for qualified people wanting to be part of a global research network while living in Queensland.”

Chlamydia is the most common sexually transmitted infection (STI) in the world, and the most reported among young people in Australia. In 2021, there were 22,000 reported cases of chlamydia in Queensland, and some 129 million infections reported worldwide in 2020.

While chlamydia can be treated, there is currently no vaccine to prevent infection. If left untreated it can lead to infertility and in pregnant women can result in foetal eye and lung infections.

The importance of investigating chlamydia vaccine candidates has obvious potential social and economic benefits locally, but the real benefits will likely be seen in low- and middle-income countries where accurate diagnostic testing is largely unavailable.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.